| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,252 |
2,699 |
$129K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
239 |
214 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
554 |
242 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
354 |
170 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
17 |
13 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31 |
25 |
$873.60 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
14 |
$566.93 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
32 |
25 |
$287.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
62 |
53 |
$23.05 |
| 99490 |
Ccm add 20min |
12 |
12 |
$10.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
43 |
37 |
$3.38 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
44 |
38 |
$0.00 |